Abstract:This study presents a paclitaxel (PTX) based polymeric prodrug (FCPTX) using functionalized Pluronic-b-poly(epsilon-caprolactone) bearing carboxyl groups [pluronic-b-poly(epsilon-caprolactone-co-6-carboxylic-s-caprolactone), Pluronic-b-P(CL-co-CCL), FC] as the substrate by a dicyclohexylcarbodiimide/4-dimethylaminopyridine-catalyzed (DCC/DMAP-catalyzed) esterification reaction. High Performance Liquid Chromatography (HPLC) and H-1 NMR. were employed together to prove the successful reaction and confirmed the structure and composition of FCPTX. The result revealed that the 2'-OH of PTX participated in reaction and the PTX content in FCPTX was up to 18.3 wt%. The polymeric prodrug could self-assemble into micelles via an emulsion/solvent evaporation technique. Furthermore, the micelle was used as the nanomicellar carrier for delivery of free PTX. TEM and DLS were used to study the size and morphologies of the FCPTX micelles and PTX-loaded FCPTX (PTX/FCPTX) micelles. The results demonstrated that the two micelles were spherical spheres with narrow distribution and the size of PTX/FCPTX micelles was larger than that of FCPTX micelles due to the micellar core was enlarged by the loaded drug. The drug loading content (DLC) and drug loading efficiency (DLE) demonstrated that the great drug loading capability of FCPTX for free PTX which could be attributed to the fact that the excellent compatibility between drug and micellar core. The sustained in vitro release of PTX/FCPTX was due to that the forceful intermolecular interaction between conjugated PTX on the polymer and the encapsulated PTX, also, the forceful intermolecular interaction led to the high residual of PTX (only 33.0% total release after 72 h at pH 7.4). However, in the lower pH environment, the drug release was accelerated due to hydrolysis of ester bond and disaggregation of micelles. In vitro antitumor experiments showed that the cytotoxicity of the conjugated PTX was reduced due to that the 2'-OH of PTX was reacted and the drug activity was crippled. The PTX/FCPTX micelles revealed high antitumor activity due to the high cellular accumulation by micelle delivery. Subsequently, the great blood compatibility of FCPTX micelles and PTX/FCPTX micelles were obtained. All of the results demonstrated the use of the polymeric conjugated PTX as the core of the polymericrnicelles afforded an ideal affinity site for free PTX and had a marvelous potential in combination chemotherapy.

Entrapping Instantly-Cleaved CPT Prodrugs in Polymeric Micelles for CPT Delivery

Linear-like polypeptide-based micelle with pH-sensitive detachable PEG to deliver dimeric camptothecin for cancer therapy

Dimeric camptothecin-loaded RGD-modified targeted cationic polypeptide-based micelles with high drug loading capacity and redox-responsive drug release capability.

Engineering of peglayted camptothecin into core-shell nanomicelles for improving solubility, stability and combination delivery

Supramolecular polymeric prodrug micelles for efficient anticancer drug delivery

In Situ Encapsulation of Camptothecin by Self-Assembly of Poly(acrylic acid)-b-Poly(N-Isopropylacrylamide) and Chitosan for Controlled Drug Delivery

Unimolecular Micelles of Camptothecin-Bonded Hyperbranched Star Copolymers Viaβ-Thiopropionate Linkage: Synthesis and Drug Delivery.

Synthesis and Properties of the Poly(ε-caprolactone)-paclitaxel Prodrug

Prostate-Specific Membrane Antigen and Esterase Dual Responsive Camptothecin–Oligopeptide Self-Assembled Nanoparticles for Efficient Anticancer Drug Delivery

Enzyme sensitive, surface engineered nanoparticles for enhanced delivery of camptothecin

Combinatorial Targeting Polymeric Micelles for Anti-Tumor Drug Delivery.

Facile synthesis of GSH-triggered skeleton-cleavable hyperbranched polymer prodrug as unimolecular micelles for tumor-specific camptothecin delivery

Preparation of Chondroitin Sulfate-G-poly(ε-caprolactone) Copolymers As a CD44-targeted Vehicle for Enhanced Intracellular Uptake.

Procedurally Targeted Delivery of Antitumor Drugs Using FAPα-Responsive TPGS Dimer-Based Flower-like Polymeric Micelles.

Concurrent Drug Unplugging and Permeabilization of Polyprodrug‐Gated Crosslinked Vesicles for Cancer Combination Chemotherapy

Cross-Linked Poly(cyclotriphosphazene-co-phloretin) Microspheres and Their Application for Controlled Drug Delivery

Acidity-responsive shell-sheddable camptothecin-based nanofibers for carrier-free cancer drug delivery

Reduction-sensitive Poly(ethylene Glycol)–polypeptide Conjugate Micelles for Highly Efficient Intracellular Delivery and Enhanced Antitumor Efficacy of Hydroxycamptothecin

Cell-Penetrating Peptide Modified PEG-PLA Micelles for Efficient PTX Delivery

Supramolecular PEGylation of Camptothecin for Cancer Therapy

Transformative Nanomedicine of an Amphiphilic Camptothecin Prodrug for Long Circulation and High Tumor Uptake in Cancer Therapy.